MORRISVILLE, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ:LQDA) today reported financial results for the first quarter ended March 31, 2024. The company will host a webcast at 8:30 a.m. ET on May 14, 2024 to discuss the financial results and provide a corporate update. Court denied United Therapeutics' Request for Injunctive Relief in Lawsuit Against FDA. UTHR filed a separate lawsuit against FDA in the U.S. District Court for the District of Columbia (Case No. 1:24-cv00484- JDB), and ...

or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) Commission File Number: 001-39724 LIQUIDIA CORPORATION ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal quarter ended March 31, 2024 (Exact Name of Registrant as Specified in Its Charter) | Delaware | 85-1710962 | | - ...

MORRISVILLE, N.C., May 10, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ:LQDA) announced today the company will present data related to the investigational use of L606 (liposomal treprostinil) inhalation suspension in people with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD) at the American Thoracic Society (ATS) 2024 International Conference, taking place May 17-22, 2024, in San Diego, California. Rajeev Saggar, MD, chief medical ...

Liquidia Corporation (NASDAQ:LQDA) Q4 2023 Earnings Conference Call March 13, 2024 8:30 AM ET Company Participants Roger Jeffs - CEO Scott Moomaw - CCO Michael Kaseta - COO & CFO Rajeev Saggar - CMO Jason Adair - CBO Rusty Schundler - General Counsel Conference Call Participants Mary Kate Davis - Bank of America Julian Harrison - BTIG Serge Belanger - Needham & Company Matt Kaplan - Ladenburg Thalmann Kambiz Yazdi - Jefferies Operator Good morning, and welcome everyone to the Liquidia Corporation Full-Year ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39724 LIQUIDIA CORPORATION (Exact Name of Registrant as Specified in Its Charter) | Delaware | 85-1710962 | | --- | --- | | ( ...

Exhibit 99.1 Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update MORRISVILLE, N.C., March 13, 2024 – Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) today reported financial results for the full year ended December 31, 2023. The Company will host a webcast at 8:30 a.m. ET to discuss the 2023 financial results and provide a corporate update. Roger Jeffs, Liquidia's Chief Executive Officer, said: "Based on our success last year, we are preparing to become ...

Liquidia will pursue final FDA approval for YUTREPIA™ (treprostinil) inhalation Liquidia will immediately request that District Court set aside injunction tied to '793 patent MORRISVILLE, N.C., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ:LQDA) (Liquidia or the Company) announced that the U.S. Court of Appeals for the Federal Circuit (Federal Circuit) today affirmed the earlier decision by the Patent Trial and Appeal Board (PTAB) which found all claims of U.S. Patent No. 10,716,793 ('793 P ...

Liquidia Corporation (NASDAQ:LQDA) Q3 2023 Earnings Conference Call November 7, 2023 8:30 AM ET Company Participants Jason Adair - Chief Business Officer Roger Jeffs - Chief Executive Officer Scott Moomaw - Chief Commercial Officer Michael Kaseta - Chief Financial Officer Rajeev Saggar - Chief Medical Officer Rusty Schundler - General Counsel Conference Call Participants Greg Harrison - Bank of America Serge Belanger - Needham Kambiz Yazdi - Jefferies Julian Harrison - BTIG Operator Good morning, and welcom ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal quarter ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39724 LIQUIDIA CORPORATION (Exact Name of Registrant as Specified in Its Charter) | Delaware | 85-1710962 | ...

Liquidia Corporation (NASDAQ:LQDA) Q2 2023 Earnings Conference Call August 10, 2023 8:30 AM ET Company Participants Jason Adair - Chief Business Officer Roger Jeffs - Chief Executive Officer Rusty Schundler - General Counsel Mike Kaseta - Chief Financial Officer Rajeev Saggar - Chief Medical Officer Conference Call Participants Mary Kate - Bank of America Julian Harrison - BTIG Serge Belanger - Needham Kambiz Yazdi - Jefferies Matthew Kaplan - Ladenburg Thalmann Operator Good morning, and welcome everyone t ...